The management of gastro-oesophageal reflux disease

被引:8
|
作者
Keung, Charlotte [1 ,2 ]
Hebbard, Geoffrey [2 ]
机构
[1] Launceston Gen Hosp, Launceston, Tas, Australia
[2] Royal Melbourne Hosp, Melbourne, Vic, Australia
关键词
endoscopy; gastro-oesophageal reflux disease; histamine H2 antagonists; proton pump inhibitors;
D O I
10.18773/austprescr.2016.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
If there are no features of serious disease, suspected gastro-oesophageal reflux disease can be initially managed with a trial of a proton pump inhibitor for 4-8 weeks. This should be taken 30-60 minutes before food for optimal effect. Once symptoms are controlled, attempt to withdraw acid suppression therapy. If symptoms recur, use the minimum dose that controls symptoms. Patients who have severe erosive oesophagitis, scleroderma oesophagus or Barrett's oesophagus require long-term treatment with a proton pump inhibitor. Lifestyle modification strategies can help gastro-oesophageal reflux disease. Weight loss has the strongest evidence for efficacy. Further investigation and a specialist referral are required if there is no response to proton pump inhibitor therapy. Atypical symptoms or signs of serious disease also need investigation.
引用
收藏
页码:6 / 10
页数:5
相关论文
共 50 条